Why eCOA usability problems start upstream in trial design and workflow, not inside the app itself.
- Inside Versiti's Data Strategy: Building AI-Ready Research Systems
- How Versiti Turns Data Into A Lifeline For Rare Blood Patients
- What Is Shadow AI, And How Does It Impact Clinical Trial Tech?
- Will AI And Agile Project Management Help Advance RBM?
- Building A Clinical Trial Tech Stack That Actually Works
- The Integration Dilemma: Who Decides Which Tech Stack Wins?
- Why Clinical Trial Sites Are Drowning In Tech Chaos
- The Risks And Unresolved Rules Of Real-Time Clinical Trials
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
5 Trends To Watch This Year
Explore 2026 policy trends across drug‑pricing actions, affordability pressures, value‑driven evaluation, shifts in global innovation, and new AI regulatory applications.
-
Why Oncology Drug Development Lags In Digital Biomarkers
Despite technological advances, oncology drug development research has lagged in adopting wearable digital biomarkers. Explore this space's unique challenges and the benefits of wearable technology.
-
Clinical Data Like You've Never Seen It Before
In a recent webinar, experts from Revvity Signals Software explored how solutions like its Spotfire platform enable better, more streamlined clinical studies.
-
RTSM/IRT In Clinical Trials: The Complete Guide
RTSM/IRT systems are essential to modern clinical trials. This guide explores how to implement and optimize them to boost efficiency, streamline operations, uphold study integrity, and ensure compliance.
-
Kicking Off A Clinical Trial The Right Way - With Seamless Digital Consent
Read this blog to learn more about how eConsent can enhance participant engagement and retention when used both onsite and remotely.
-
Navigating eCOA Licensing And Localization In Clinical Trials
eCOA has been key in trials for 20 years, but issues like licensing, localization, and execution quality still challenge sponsors.
-
Patient-Centric Clinical Trials: The Power Of Choice
Patient-centric trials, advocated by the FDA, focus on offering choices to improve engagement, diversity, and data quality. Explore how expanding patient choice can benefit clinical trials.
-
Top 5 Dos And Don'ts Of RTSM
Discover best practices and common pitfalls for sponsors and vendors in RTSM as well as how to optimize your study by leveraging vendor expertise, avoiding delays, and embracing innovation.
-
Do CROs Need To Reinvent Themselves In 2025?
Facing economic pressures, regulatory changes, and technological advancements, CROs must redefine their value propositions and discuss the need for reinvention in 2025 to accelerate into the future.
-
Mid-Study Randomization: Ensuring Data Integrity In Oncology Trials
Miscommunication between supply chain vendors risks costly delays. Discover how unifying physical and digital operations catches issues before they disrupt a trial.
- Designing eCOA Technology Patients Can Actually Use
- Clinical Trial Technology Doesn't Fail – It Fails At The Handoff
- Inside Versiti's Data Strategy: Building AI-Ready Research Systems
- How Versiti Turns Data Into A Lifeline For Rare Blood Patients
- Building A Clinical Trial Tech Stack That Actually Works
RECENT NEWSLETTERS
- 07.09.26 -- AI Governance, Real-Time Trials, And Hidden Risks to Watch
- 07.03.26 -- Best Of June: AI, Data, And What's Fixing Trial Execution
- 07.02.26 -- How AI And Real-Time Tech Are Changing Trial Execution
- 06.25.26 -- How AI, Data, And Workflows Are Fixing Trial Execution
- 06.18.26 -- AI, eSource, And Site Tech: What's Actually Working In Trials